Geneos Wealth Management Inc. Ascendis Pharma A/S Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 76 shares of ASND stock, worth $10,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76
Previous 75
1.33%
Holding current value
$10,829
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ASND
# of Institutions
234Shares Held
58.9MCall Options Held
208KPut Options Held
321K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.38 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$788 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$711 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$634 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$597 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.95B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...